From: Role of MRI in diagnosis of prostate cancer and correlation of results with transrectal ultrasound guided biopsy “TRUS”
MRI MRS
Biopsy
Total
Malignant
Benign
Positive
14 (46.7%) TP
3 (10.0%) FP
14 (56.7%)
Negative/ non-specific
8 (26.7%) FN
5 (16.7%) TN
13 (43.3%)
22 (73.3%)
8 (26.7%)
30 (100.0%)
Kappa (95% CI)
0.218 (0.000–0.552)
P
0.201